Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oral Anti-Tumor Drugs”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Not applicableUnknownNCT03605186
What this trial is testing

Prevention of Oral Mucositis After Using Chamomile Oral Cryotherapy Versus Oral Cryotherapy in Pediatric Cancer Patients Receiving Chemotherapy.

Who this might be right for
Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy
Cairo University 20
Not applicableStudy completedNCT03454971
What this trial is testing

Health Course of Patients Undergoing Per os Anti-cancer Therapy.

Who this might be right for
Cancer
Groupe Hospitalier Mutualiste de Grenoble 64
Not applicableActive Not RecruitingNCT07054528
What this trial is testing

Multicentre Real-life Data Collection Study With CareMin650™ in the Prevention and Treatment of Oral Mucositis and Radio- and/or Chemo-induced Dermatitis

Who this might be right for
Oral Mucositis (Ulcerative)Oral Mucositis (Ulcerative) Due to Antineoplastic TherapyOral Mucositis (Ulcerative) Due to Radiation+1 more
Centre Hospitalier de Valenciennes 33,000
Testing effectiveness (Phase 2)Looking for participantsNCT05941507
What this trial is testing

Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
LigaChem Biosciences, Inc. 300
Testing effectiveness (Phase 2)Study completedNCT05154201
What this trial is testing

Treatment of Patients With Advanced Solid Tumors With Oral Agent ORIN1001 and in Combination With Standard of Care.

Who this might be right for
Effect of Drug
Orinove, Inc. 150
Not applicableWithdrawnNCT04508855
What this trial is testing

Management of Atrial Fibrillation in Patients With Cancer (MAFIC Study)

Who this might be right for
CancerAtrial Fibrillation
AHEPA University Hospital
Early research (Phase 1)Study completedNCT00264446
What this trial is testing

ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic Resection

Who this might be right for
Neoplasms
Adherex Technologies, Inc.
Not applicableStudy completedNCT01036633
What this trial is testing

Oral Mucositis in Patients Undergoing Antineoplastic Chemotherapy

Who this might be right for
Oral Mucositis
University of Arkansas 4
Testing effectiveness (Phase 2)WithdrawnNCT06708702
What this trial is testing

Copaíba-based Mouthwash in Oral Mucotitis Prevention and Treatment in Oral Cancer Patients During Radioteraphy

Who this might be right for
Oral MucositisOral Mucositis (Ulcerative) Due to RadiationOral Mucositis (Ulcerative) Due to Antineoplastic Therapy+1 more
Instituto Nacional de Cancer, Brazil
Testing effectiveness (Phase 2)Study completedNCT01941771
What this trial is testing

Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer

Who this might be right for
Breast Cancer
University of Aarhus 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT05172258
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+12 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00002188
What this trial is testing

ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
Anderson Clinical Research 27
Early research (Phase 1)Looking for participantsNCT03816345
What this trial is testing

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Who this might be right for
Autoimmune DiseaseCrohn DiseaseDermatomyositis+11 more
National Cancer Institute (NCI) 300
Early research (Phase 1)Ended earlyNCT01347866
What this trial is testing

Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer

Who this might be right for
Advanced Cancer
Pfizer 105
Not applicableUnknownNCT03630692
What this trial is testing

Safety and Compliance of Renal Cancer Patients Treated by Non-IV Drugs

Who this might be right for
Metastatic Renal CancerStage III Renal Cell Cancer
Institut Cancerologie de l'Ouest 158
Large-scale testing (Phase 3)Active Not RecruitingNCT04964934
What this trial is testing

Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)

Who this might be right for
ER-Positive HER2-Negative Breast Cancer
AstraZeneca 315
Not applicableStudy completedNCT02247583
What this trial is testing

Investigating Patient Satisfaction With Oral Anti-Cancer Treatment

Who this might be right for
Clear Cell Renal Cell Carcinoma
KU Leuven 90
Early research (Phase 1)Study completedNCT00055380
What this trial is testing

Chemical and Genetic Effects of the Experimental Anti-Cancer Drugs in Cheek Cells in Cancer Patients

Who this might be right for
Cancer
National Institute of Dental and Craniofacial Research (NIDCR) 120
Testing effectiveness (Phase 2)Study completedNCT00095927
What this trial is testing

Randomized Amifostine For SCCHN

Who this might be right for
Chemotherapeutic Agent ToxicityHead and Neck CancerMucositis+2 more
Dana-Farber Cancer Institute 58
Early research (Phase 1)Active Not RecruitingNCT04704661
What this trial is testing

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Who this might be right for
Advanced Breast CarcinomaAdvanced Colon CarcinomaAdvanced Colorectal Carcinoma+37 more
National Cancer Institute (NCI) 51
Load More Results
52